Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasonographic changes in median nerve cross-sectional area in the elderly: effects of aging and type 2 diabetes.

BMC geriatrics·2025
Same author

Long COVID-19: a Four-Year prospective cohort study of risk factors, recovery, and quality of life.

BMC infectious diseases·2025
Same author

The incidence, clinical features and outcome of urinary tract infections in geriatric patients: A prospective longitudinal study.

IJID regions·2024
Same author

The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study.

Viruses·2023
Same author

Application of Mathematical Modeling in Prediction of COVID-19 Transmission Dynamics.

Arabian journal for science and engineering·2022
Same author

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents.

Hepatic medicine : evidence and research·2014

Related Experiment Video

Updated: Jul 5, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Acute hepatitis C: a systematic review.

Sanaa M Kamal1

  • 1Department of Gastroenterology and Liver Disease, Ain Shams Faculty of Medicine, Cairo, Egypt.

The American Journal of Gastroenterology
|May 15, 2008
PubMed
Summary
This summary is machine-generated.

Early treatment of acute hepatitis C virus (HCV) infection offers high cure rates, preventing chronic disease. Reliable predictors for spontaneous HCV resolution are lacking, making timely intervention crucial for patient outcomes.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) incidence has declined but remains prevalent in specific populations.
  • Acute HCV infections are often asymptomatic, delaying diagnosis and intervention.
  • Most acute HCV infections progress to chronic liver disease without spontaneous resolution.

Purpose of the Study:

  • To review literature for predictors of spontaneous resolution in acute hepatitis C.
  • To identify factors aiding treatment decisions during the acute phase of HCV infection.

Main Methods:

  • Conducted a MEDLINE literature search using keywords: "acute hepatitis C", epidemiology, natural history, diagnosis, transmission, and treatment.
  • Focused on identifying predictors for spontaneous resolution and treatment efficacy in acute HCV.

Main Results:

  • No reliable predictors for spontaneous HCV resolution were identified.
  • Treatment of acute HCV infection demonstrates high sustained virological response (SVR) rates (75-100%).
  • Optimizing acute HCV therapy and identifying SVR predictors remain significant clinical challenges.

Conclusions:

  • Effective diagnosis and treatment of acute HCV are critical to reduce the global burden of chronic hepatitis C.
  • Improved management of acute HCV can significantly impact morbidity and mortality, especially in endemic regions.
  • Further research is needed to optimize treatment strategies and identify predictors of successful viral eradication.